Fig. 3From: A novel signature to predict thyroid cancer prognosis and immune landscape using immune-related LncRNA pairsThe prognostic value of the signature. THCA patients were assigned to different subgroups, including sex (male and female), N stage (N0 and N1), stage (stage I + II and stage III + IV) and T stage (T1 + T2 and T3 + T4)Back to article page